Clinical Trials Logo

Diagnosis, Dual (Psychiatry) clinical trials

View clinical trials related to Diagnosis, Dual (Psychiatry).

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05115266 Not yet recruiting - Clinical trials for Diagnosis, Dual (Psychiatry)

Efficacy of Animal-assisted Therapy in Patients With Borderline Personality Disorder and Addictions.

Start date: April 30, 2022
Phase: N/A
Study type: Interventional

Animal-assisted therapy (AAT) is a complementary intervention of therapy that has shown positive results in the treatment of various pathologies. This study assesses the viability of the implementation and the effectiveness of an AAT program in patients diagnosed with borderline personality disorder and substance abuse disorder. Our hypotheses are that participation in the TAA program will reduce negative symptoms, improve the quality of life of people with dual pathology, whose mental illness is schizophrenia, and increase adherence to treatment for people with dual pathology, whose mental disorder it's schizophrenia.

NCT ID: NCT04442776 Not yet recruiting - Clinical trials for Diagnosis, Dual (Psychiatry)

Dual Integrated Attention Program (DAIP) in People With Severe Dual Diagnosis

PAI-D
Start date: September 1, 2020
Phase: N/A
Study type: Interventional

Aim: validate a Dual Integrated Attention Program (D-AIP) for mental health nursing in people with Severe Dual Diagnosis admitted to a psychiatric hospitalization unit Design: Randomized Controlled Trial. Population: Inpatients with dual diagnosis.